For this purpose, Shakil used molecular docking to investigate the effects of two antidiabetic drugs, Ertugliflozin and Sotagliflozin, and their targets, Sodium glucose cotransporter 2 and AChE, on AD. Here, ACHE is linked to Alzheimer disease.